Results 101 to 110 of about 36,320 (224)
Catalytic asymmetric formal synthesis of beraprost
Beilstein Journal of Organic Chemistry, 2015 The first catalytic asymmetric synthesis of the key intermediate for beraprost has been achieved through an enantioselective intramolecular oxa-Michael reaction of an α,β-unsaturated amide mediated by a newly developed benzothiadiazine catalyst.
Yusuke Kobayashi +2 more
doaj +1 more source
Journal of the American Heart Association: Cardiovascular and Cerebrovascular DiseaseBackground Experimental preeclampsia (ePE) has been shown to have worsened outcome from stroke. We investigated the effect of low‐dose aspirin, known to prevent preeclampsia, on stroke hemodynamics and outcome, and the association between the ...
Marilyn J. Cipolla, Sarah M. Tremble
doaj +1 more source
Partial isolation and function of the prostacyclin regulating plasma factor
, 1985 Rat aortic rings stop producing prostacyclin upon prolonged washing in buffer. This 'exhaustion' is caused by inhibition of cyclo-oxygenase, since these rings still convert cyclic endoperoxides but not arachidonic acid into prostacyclin, and most ...
D'Hondt, L. +8 more
core +1 more source
Anticoagulation strategies for pediatric continuous renal replacement therapy
Journal of Pediatric Critical CareContinuous renal replacement therapy (CRRT) in children is quite challenging to manage because of their increased propensity for circuit clotting. The anticoagulant strategies are paramount in reducing the downtime in pediatric CRRT.
Aakash Chandran Chidambaram +2 more
doaj +1 more source
Prostacyclin for pulmonary hypertension in adults
, 2005 Prostacyclin may benefit patients with pulmonary hypertension (raised blood pressure in the lungs) in the short term but studies longer in duration are required.
Paramothayan, N Shanthi +3 more
core +1 more source
Pulmonary CirculationAdhesive reactions are common complications of continuous treprostinil infusions, limiting their recommended use as a treatment for severe pulmonary hypertension.
Nidhy P. Varghese +4 more
doaj +1 more source
Prostanoid therapies in the management of pulmonary arterial hypertension
Therapeutics and Clinical Risk Management, 2015 Barbara L LeVarge Department of Pulmonary and Critical Care Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USA Abstract: Prostacyclin is an endogenous eicosanoid produced by endothelial cells; through actions on vascular smooth-muscle ...
LeVarge BL
doaj
Prostacyclin release from the rat isolated heart
, 1982 Prostacyclin release from the rat isolated ...
GJ Dusting (15839609) +1 more
core
Терапевтический архив, 2010 Aim. To reveal changes in the thromboxane-prostacyclin balance and platelet aggregability in patients with various variants of minor cardiac abnormalities. Subjects and methods: Six-five patients (mean age 23.0±0.7 years) with minor cardiac abnormalities
Aleksandr Valentinovich Yagoda +3 more
doaj
, 2002 Prostacyclin is an endogenous mediator that shows potent platelet inhibitory activity and powerful relaxation of peripheral resistance vessels. Prostacyclin receptor agonists are valuable drugs in the treatment of various vascular diseases spanning ...
Friederike Stoll +5 more
core